Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
A multi-centre phase I study to evaluate the safety and tolerability of a heterologous prime-boost vaccination with INX102-3697 HBV pDNA/INX-102-00557 HBV MVA in healthy volunteers and HBeAg+ chronic hepatitis patients

Proposed period of release:
01/03/2008 to 01/03/2010

Name of the Institute(s) or Company(ies)
GENimmune N.V., ;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Modified Vaccinia virus Ankara (MVA), strain MVATGN33

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
MVAOrthopoxvirusVaccinia virusModified Virus Ankara

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known